Literature DB >> 7426085

Apoproteins and lipids as discriminators of severity of coronary heart disease.

W F Riesen, R Mordasini, C Salzmann, A Theler, H P Gurtner.   

Abstract

Serum apoprotein and lipid concentrations were measured in 63 patients undergoing coronary angiography. Thirty-eight patients had 50% or higher grade stenoses, 25 had chest pain, but no significant stenoses. Among the patients with higher grade stenoses 71% had hyperlipoproteinemias as opposed to 12% in patients without stenoses. As compared to suitable normal controls, patients with angiographically documented coronary heart disease showed significant changes in all lipid and apoprotein concentrations under study. However, differences between the two patients groups were also noted. Among these, apo A-I, A-II and B, total cholesterol and LDL cholesterol were statistically significant. These results indicate that apoprotein A and B levels, total cholesterol and LDL cholesterol are good discriminators of the severity of coronary heart disease, while HDL cholesterol is a more suitable parameter for epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426085     DOI: 10.1016/0021-9150(80)90104-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Apoproteins: predictors of coronary heart disease?

Authors:  M Ball; J I Mann
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

2.  Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia.

Authors:  J M Bard; G Luc; P Douste-Blazy; P Drouin; O Ziegler; B Jacotot; C Dachet; J L De Gennes; J C Fruchart
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Sources of interindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic.

Authors:  G Pairitz; J Davignon; H Mailloux; C F Sing
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

4.  The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects.

Authors:  R I Press; J Geller; G W Evans
Journal:  West J Med       Date:  1990-01

5.  Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction.

Authors:  M Sewdarsen; R K Desai; S Vythilingum; N Shah; M C Rajput
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

6.  Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia.

Authors:  B Teng; G R Thompson; A D Sniderman; T M Forte; R M Krauss; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Quantitation of baboon lipoproteins by high performance gel exclusion chromatography.

Authors:  M C Williams; R S Kushwaha; H C McGill
Journal:  Lipids       Date:  1987-05       Impact factor: 1.880

8.  [Bezafibrate in primary hyperlipidemias (author's transl)].

Authors:  J G Wechsler; V Hutt; H U Klör; G Bode; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1982-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.